Literature DB >> 19263205

Predictors of hemodynamic compromise with propofol during defibrillator implantation: a single center experience.

Khyati Pandya1, Mehul B Patel, Jaya Natla, Abhijeet Dhoble, Terry Habetler, Jeffrey Holliday, Renee Janes, Sujeeth R Punnam, Joseph C Gardiner, Ranjan K Thakur.   

Abstract

BACKGROUND: Intra-operative hypotension has been reported in cardiac resynchronization therapy defibrillator (CRT-D) clinical trials but this phenomenon is not well characterized. The purpose of this study was to understand the frequency and determinants of intra-operative hypotension in patients undergoing defibrillator implantations.
METHODS: We retrospectively reviewed clinical data of all CRT-D implantations over a 21-month period. We compared a randomly selected contemporaneous group undergoing implantable cardiac defibrillator (ICD) implantations as a reference group. Procedure protocol involved intra-arterial blood pressure monitoring throughout the case. Lidocaine (1%) was routinely used along with propofol for sedation in all patients. Procedure time was defined as the time from initial administration of lidocaine for arterial line access, to completion of defibrillator pocket closure. Cumulative dose of propofol was calculated in each patient. Hypotension was defined as a fall in the systolic blood pressure of >or=30% from baseline or a systolic blood pressure of <or=80 mm Hg for >3 min. CRT-D and ICD patients were divided into hypotensive and non-hypotensive subsets.
RESULTS: The incidence of hypotension in the CRT-D group (N = 100) was 56%, as compared to 40% in the ICD group (N = 97). The mean duration of procedure in the CRT-D group was 114 +/- 95 min in the hypotensive subset versus 69 +/- 31.9 min in the non-hypotensive subset (p = 0.0015). The mean NYHA class in the hypotensive subset of the CRT-D group was 2.85 +/- 1.2 vs 2.2 +/- 1.5 in the non-hypotensive subset (p = 0.0179). Cumulative dose of propofol in the hypotensive subset of the CRT-D group was 386 +/- 22 mg, while that in the non hypotensive subset was 238.3 +/- 17 mg (p < 0.0001). Creatinine clearance in the hypotensive subset of the CRT-D group was 63.8 +/- 12.8 ml/min, while that in the non-hypotensive subset was 78.7 +/- 23.5 ml/min (p = 0.003). Patients in the CRT-D group who developed hypotension had a lower left ventricular ejection fraction of 21.1 +/- 10.2% versus 29 +/- 14.8% in the non-hypotensive subset (p = 0.0035).
CONCLUSIONS: Hypotension is a common occurrence during defibrillator implantation under conscious sedation. Risk factors for significant hypotension include: higher NYHA class, lower left ventricular ejection fraction, lower creatinine clearance, higher doses of propofol and longer procedure times.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19263205     DOI: 10.1007/s10840-008-9355-6

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  20 in total

1.  Cardiac resynchronization in chronic heart failure.

Authors:  William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

2.  Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program.

Authors:  Angel R León; William T Abraham; Anne B Curtis; James P Daubert; Westby G Fisher; John Gurley; David L Hayes; Randy Lieberman; Susan Petersen-Stejskal; Kevin Wheelan
Journal:  J Am Coll Cardiol       Date:  2005-12-20       Impact factor: 24.094

3.  Hemodynamic and cardiodynamic effects of propofol and etomidate: negative inotropic properties of propofol.

Authors:  T Brüssel; J L Theissen; G Vigfusson; P P Lunkenheimer; H Van Aken; P Lawin
Journal:  Anesth Analg       Date:  1989-07       Impact factor: 5.108

4.  Propofol impairment of mitochondrial respiration in isolated perfused guinea pig hearts determined by reflectance spectroscopy.

Authors:  K A Schenkman; S Yan
Journal:  Crit Care Med       Date:  2000-01       Impact factor: 7.598

5.  Sympathetic and hemodynamic effects of moderate and deep sedation with propofol in humans.

Authors:  Thomas J Ebert
Journal:  Anesthesiology       Date:  2005-07       Impact factor: 7.892

Review 6.  Propofol: therapeutic indications and side-effects.

Authors:  Paul E Marik
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

7.  Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.

Authors:  James B Young; William T Abraham; Andrew L Smith; Angel R Leon; Randy Lieberman; Bruce Wilkoff; Robert C Canby; John S Schroeder; L Bing Liem; Shelley Hall; Kevin Wheelan
Journal:  JAMA       Date:  2003-05-28       Impact factor: 56.272

8.  Predicting blood pressure change caused by rapid injection of propofol during anesthesia induction with a logistic regression model.

Authors:  Ruey-Horng Rau; Yu-Chuan Li; Jen-Kun Cheng; Chien-Chuan Chen; Yuan-Pi Ko; Chun-Jen Huang
Journal:  Acta Anaesthesiol Taiwan       Date:  2004-06

9.  Asystole following left ventricular pacing.

Authors:  Rebecca W Lai; Kent J Volosin
Journal:  Pacing Clin Electrophysiol       Date:  2004-06       Impact factor: 1.976

10.  Propofol metabolites in man following propofol induction and maintenance.

Authors:  P Favetta; C S Degoute; J P Perdrix; C Dufresne; R Boulieu; J Guitton
Journal:  Br J Anaesth       Date:  2002-05       Impact factor: 9.166

View more
  2 in total

Review 1.  Sedation in the Electrophysiology Laboratory: A Multidisciplinary Review.

Authors:  Neal S Gerstein; Andrew Young; Peter M Schulman; Eric C Stecker; Peter M Jessel
Journal:  J Am Heart Assoc       Date:  2016-06-13       Impact factor: 5.501

2.  Feasibility and safety of using local anaesthesia with conscious sedation during complex cardiac implantable electronic device procedures.

Authors:  Elif Kaya; Hendrik Südkamp; Julia Lortz; Tienush Rassaf; Rolf Alexander Jánosi
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.